Skip to main content
. Author manuscript; available in PMC: 2006 Mar 6.
Published in final edited form as: Diabetes. 2006 Feb;55(2):517–522. doi: 10.2337/diabetes.55.02.06.db05-1066

FIG. 1.

FIG. 1

Relationship between initial fractional reduction in IVGTT insulin area and corresponding diabetes incidence rates in the troglitazone arm of the TRIPOD study (•) and in the PIPOD study (▪). Insulin output was assessed as the total area under the insulin curve during IVGTTs. Reductions in output were calculated between enrollment into each study and the initial on-treatment IVGTT, which occurred after 3 months in the TRIPOD study and after 1 year in the PIPOD study. Symbols represent the low, middle, and high tertile of change in each study. Lines represent best linear fits of data for each study.